You have no items in your shopping cart.
- Item 1 of 4Human TGF-beta 1 Protein [orb257996]Featured
Active
Unconjugated
95%
12.8 kDa (monomer)
10 μg, 1 mg, 50 μg 
Human GFRA1 [orb2993981]Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 72.4 KDa. Observed: 85 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Human Lefty-A [orb2994186]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 39.1 KDa. Observed: 45-50 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human GFRA2 [orb2994496]
Unconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 74.7 KDa. Observed: 120 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human ACVR1 [orb2994792]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.6 KDa. Observed: 17 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse FSTL1 [orb2994352]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 59.6 KDa. Observed: 70-85 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse FSTL1 [orb2994353]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 33.5 KDa. Observed: 45-58 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse ALK-1 [orb2994410]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.1 KDa. Observed: 55-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human GFRA2 [orb2995054]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 47.79 KDa. Observed: 60-80 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human GFRA1 [orb2995055]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.28 KDa. Observed: 60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg
